The Latest

• July 26, 2020

  By Jet Encila

  Cipla Gets Regulatory Approval In India To Sell Favipiravir For COVID Treatment

  India has reported over 49,000 new coronavirus infections with 740 new mortalities on Friday.

  

  India has reported over 49,000 new coronavirus infections with 740 new mortalities on Friday.
• June 22, 2020

  By Jet Encila

  India's Drug Regulator Gives Cipla, Hetero Go Signal To Produce Remdesivir

  License deal with Gilead allows remdesivir to reach low- and middle-income nations.

  

  License deal with Gilead allows remdesivir to reach low- and middle-income nations.